• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Rational design of a booster vaccine against COVID-19 based on antigenic distance - Cell Host & Microbe

Mary Wilson

Well-known member
Published: July 31, 2023

DOI: https://doi.org/10.1016/j.chom.2023.07.004

Ye-Fan Hu, Terrence Tsz-Tai Yuen, Hua-Rui Gong, ..., Bao-Zhong Zhang, Hin Chu, Jian-Dong Huang

In brief

Consistent with the prediction of an in silico antigenic distance model, Hu et al. find that a SARS-CoV-1-based booster outperforms other candidates to elicit more durable and broader neutralizing responses and provides better protection against BA.2 challenge in mice. This model provides a useful strategy for designing future booster vaccines.

Highlights

  • An antigenic distance in silico model suggests SARS-CoV-1 as a better COVID-19 booster

  • A booster with SARS-CoV-1 spike induces more effective protection against BA.2 challenge

  • SARS-CoV-1-based booster elicits better breadth and durability of neutralizing response

  • This model offers a strategy for the selection of SARS-CoV-2 boosters
https://www.cell.com/cell-host-microbe/pdfExtended/S1931-3128(23)00299-8


 
Back
Top Bottom